# Clinical and Mechanistic Effects of Psilocybin in Alcohol Addicted Patients

> **NCT04141501** · PHASE2 · COMPLETED · sponsor: **University of Zurich** · enrollment: 37 (actual)

## Conditions studied

- Alcohol Use Disorder

## Interventions

- **DRUG:** Psilocybin
- **DRUG:** Placebo oral capsule

## Key facts

- **NCT ID:** NCT04141501
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-08
- **Primary completion:** 2023-03-14
- **Final completion:** 2023-09-14
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2023-09-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04141501

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04141501, "Clinical and Mechanistic Effects of Psilocybin in Alcohol Addicted Patients". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04141501. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*